VANGUARD GROUP INC 13D and 13G filings for Ocugen, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-12 4:59 pm Unchanged |
2024-09-30 | 13G | Ocugen, Inc. OCGN |
VANGUARD GROUP INC | 16,949,019 5.880% |
0 (Unchanged) |
Filing |
2024-11-04 1:43 pm Purchase |
2024-09-30 | 13G | Ocugen, Inc. OCGN |
VANGUARD GROUP INC | 16,949,019 5.880% |
4,909,101![]() (+40.77%) |
Filing |
2024-02-13 5:09 pm Purchase |
2023-12-29 | 13G | Ocugen, Inc. OCGN |
VANGUARD GROUP INC | 12,039,918 4.690% |
180,775![]() (+1.52%) |
Filing |
2023-02-09 11:27 am Purchase |
2022-12-30 | 13G | Ocugen, Inc. OCGN |
VANGUARD GROUP INC | 11,859,143 5.420% |
1,253,649![]() (+11.82%) |
Filing |
2022-02-10 08:28 am Purchase |
2021-12-31 | 13G | Ocugen, Inc. OCGN |
VANGUARD GROUP INC | 10,605,494 5.320% |
1,530,501![]() (+16.87%) |
Filing |
2021-02-10 11:40 am Purchase |
2020-12-31 | 13G | Ocugen, Inc. OCGN |
VANGUARD GROUP INC | 9,074,993 5.600% |
9,074,993![]() (New Position) |
Filing |